Accuracy of a GFR Estimating Equation Over Time in People With a Wide Range of Kidney Function

Tufts Medical Center, Boston, MA 02111, USA.
American Journal of Kidney Diseases (Impact Factor: 5.76). 04/2012; 60(2):217-24. DOI: 10.1053/j.ajkd.2012.01.024
Source: PubMed

ABSTRACT Change in glomerular filtration rate (GFR) is important for clinical decision making. GFR estimates from serum creatinine level provide an unbiased but imprecise estimate of GFR at single time points. However, the accuracy of estimated GFR over time is not well known.
Longitudinal study of diagnostic test accuracy.
4 clinical trials with longitudinal measurements of GFR and serum creatinine on the same day, including individuals with and without kidney disease with a wide range of kidney function, diverse racial backgrounds, and varied clinical characteristics.
GFR estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.
GFR measured using urinary clearance of (125)I-iothalamate.
Data included 19,735 GFR measurements in 3,531 participants during a mean follow-up of 2.6 years. Mean values at baseline for measured and estimated GFR and error (measured GFR - estimated GFR) were 73.1 (95% CI, 71.6 to 74.5), 72.7 (95% CI, 71.5 to 74.0), and 0.14 (95% CI, -0.35 to 0.63) mL/min/1.73 m(2), respectively. Mean rates of change in measured and estimated GFR and error were -2.3 (95% CI, -2.4 to -2.1), -2.2 (95% CI, -2.4 to -2.1), and -0.09 (95% CI, -0.24 to 0.05) mL/min/1.73 m(2) per year (P < 0.001, P < 0.001, and P = 0.2, respectively). Variability (ie, standard deviation) among participants in rate of change in measured GFR, estimated GFR, and error was 4.3, 3.4, and 3.3 mL/min/1.73 m(2) per year, respectively. Only 15% of participants had a rate of change in error >3 mL/min/1.73 m(2) per year, and only 2% had a rate of change in error >5% per year.
Participants' characteristics were not available over time.
The accuracy of GFR estimates did not change over time. Clinicians should interpret changes in estimated GFR over time as reflecting changes in measured GFR rather than changes in errors in the GFR estimates in most individuals.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to analyze the early and late outcomes of patients who require a suprarenal aortic cross-clamp during elective open repair of an abdominal aortic aneurysm (AAA).
    Journal of Vascular Surgery 05/2014; 58(2). DOI:10.1016/j.jvs.2014.04.034 · 2.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: As yet little is known about the effect of delayed separation of whole blood stored at room temperature on the stability of the kidney function markers creatinine and cystatin C. We used plasma samples of 45 patients with a wide range of creatinine and cystatin C concentration. Samples were sent by post as whole blood, and differences in creatinine and cystatin C concentrations when measured (by enzymatic assay and PETIA, respectively) in plasma separated shortly after blood withdrawal or in plasma obtained after delayed separation at 24, 48 and 72 hours. Intra- and inter-assay variability was assessed and total change limit was calculated to assess analyte stability. Total change limit was 3.3% for creatinine and 3.9% for cystatin C. In whole blood creatinine and cystatin C remained stable up to 48 hours. Delayed separation of whole blood did not induce more variability in measured concentrations of both analytes. Glomerular filtration rate estimated with the CKD-EPI equations showed less than 3 ml/min/1.73m(2) difference when using creatinine or cystatin C concentration measured in plasma separated up to 48 hours after blood withdrawal compared to plasma separated shortly after blood withdrawal. The new CKD-EPI equation that uses creatinine as well as cystatin C to estimate GFR showed even at 72 hours less than 3 ml/min/1.73m(2) difference. Creatinine and cystatin C remain stable in whole blood stored at room temperature up to 48 hours before separation, and changes in these analytes during this time period do not affect variability and eGFR.
    Clinical biochemistry 07/2013; 46(15). DOI:10.1016/j.clinbiochem.2013.06.022 · 2.23 Impact Factor
  • Kidney International 04/2014; 85(4):723-7. DOI:10.1038/ki.2013.506 · 8.52 Impact Factor